Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05591066 · ClinicalTrials.gov registry record · NA

The Patient and Family Centered I-PASS LISTEN Study: Language, Inclusion, Safety, and Teamwork for Equity Now

A NA study of Communication, sponsored by Boston Children's Hospital.

Recruiting
Registry status
NA
Development phase
14,400
Enrollment target
8
Study locations

NCT05591066 is a NA study of Communication that is actively recruiting participants, run by Boston Children's Hospital. The registered enrollment target is 14,400 participants, above the 997-participant average among 34 other Communication trials with a reported enrollment target (1344% higher). The trial reports 8 study locations across 7 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05591066, a NA study of Communication, is actively recruiting participants, sponsored by Boston Children's Hospital.

RECRUITING
Registry status
NA
Development phase
14,400 participants
Enrollment target
8
Study locations

Study Summary

In 2014, a team of parents, nurses, and physicians created Patient and Family Centered I-PASS (PFC I-PASS), a bundle of communication interventions to improve the quality of information exchange between physicians, nurses, and families, and to better integrate families into all aspects of daily decision making in hospitals. PFC I-PASS changed how doctors and nurses talk to patients and families on rounds when they're admitted to the hospital. (Rounds are when a team of doctors visit patients every morning to do a checkup and make a plan for the day.) Rounds used to happen in a way that left out patients and families. Doctors talked at, not with patients, used big words and medical talk, and left nurses out. PFC I-PASS changed rounds by including families and nurses, using simple non-medical words, and talking in an organized way so nothing is left out. When PFC I-PASS was put in place in 7 hospitals, patients had fewer adverse events and better hospital experience. But it didn't focus on how to talk with patients with language barriers. This project builds upon upon PFC I-PASS to make it better and focus on the special needs of patients who speak languages other than English. This new intervention is known as PFC I-PASS+. PFC I-PASS+ includes all parts of PFC I-PASS plus having interpreters on and after rounds and training doctors about communication and cultural humility. The study team will now conduct a stepped-wedge cluster randomized trial to compare the effectiveness of PFC I-PASS+ and PFC I-PASS to usual care at 8 hospitals.

Conditions Studied

Interventions

  • BEHAVIORAL PFC I-PASS Intervention
  • BEHAVIORAL PFC I-PASS+ Intervention

Study Locations (8)

California

  • Children's Hospital Los Angeles - Los Angeles
  • UCSF Benioff Children's Hospital of Oakland - Oakland

Alabama

  • University of Alabama at Birmingham - Birmingham

Nebraska

  • University of Nebraska Medical Center - Omaha

New York

  • Children's Hospital at Montefiore - The Bronx

Ohio

  • The Research Institute of Nationwide Children's Hospital - Columbus

Pennsylvania

  • UPMC Children's Hospital of Pittsburgh - Pittsburgh

Texas

  • Northwest Texas Healthcare System - Amarillo

Trial Details

FieldValue
Enrollment Target 14,400 participants
Start Date 2024-03-26
Est. Completion 2028-11-01
Phase NA

Sponsor

Boston Children's Hospital

462 total trials

What the Registry Record Tells You About NCT05591066

The ClinicalTrials.gov registry entry for NCT05591066 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 14,400 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 997-participant average among 34 other Communication trials with a reported enrollment target (1344% higher). The listed sponsor is Boston Children's Hospital, which has 462 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Communication appearing as the primary indexed condition, and to 2 interventions - of which PFC I-PASS Intervention is the first listed.

NCT05591066 reports 8 study locations spanning 7 distinct geographic areas - top geographies include California, Alabama, Nebraska.

Frequently Asked Questions

What is clinical trial NCT05591066 about?

NCT05591066 is a clinical study titled "The Patient and Family Centered I-PASS LISTEN Study: Language, Inclusion, Safety, and Teamwork for Equity Now". In 2014, a team of parents, nurses, and physicians created Patient and Family Centered I-PASS (PFC I-PASS), a bundle of communication interventions to improve the quality of information exchange between physicians, nurses, and families, and to better integrate families into all aspects of daily deci...

What is the current status of trial NCT05591066?

This trial is currently recruiting. It is a NA study. The enrollment target is 14,400 participants. The study started on 2024-03-26. Estimated completion is 2028-11-01.

What conditions does trial NCT05591066 study?

This clinical trial studies the following conditions: Communication.

What interventions are being tested in trial NCT05591066?

The interventions under investigation include: PFC I-PASS Intervention (BEHAVIORAL), PFC I-PASS+ Intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT05591066?

This trial is sponsored by Boston Children's Hospital, which has 462 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05591066 being conducted?

This trial has 8 study locations across Alabama, California, Nebraska, New York, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Communication

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.